The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
To anyone holding a half-full glass and with rose-tinted spectacles firmly in place on their face, the latest batch of real estate data has brought them back to reality with a sharp bump.
The National Association of Realtors (NAR) dampened the spirits on Thursday morning, with the news that sales of existing U.S. homes fell by 2.7% in August to an annual rate of 5.1 million.
And thus, the streak of four straight months of rising sales came to an end. Although given the fragile, stumbling recovery of the housing market, that’s akin to Cal Ripken’s consecutive games played streak for the Baltimore Orioles.
As for prices, they’re still stuck in reverse, too. The average price is currently $177,000 – about 12.5% lower than this time last year. And it’s no surprise to see repossessed homes sucking the overall market down. Lawrence Yun, chief economist at the NAR, says they’re selling for 15% to 20% less than non-repossessed homes.
- Why Housing Prices Will Keep Dropping in Value
- Housing Recovery Here We Come
- Gold: This Commodity Loves Economic Upheaval
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed